Mr James Dean Oggel, MD | |
4280 Sergeant Rd, #230, Sioux City, IA 51106-4634 | |
(712) 274-6884 | |
(712) 274-6885 |
Full Name | Mr James Dean Oggel |
---|---|
Gender | Male |
Speciality | Allergy & Immunology - Allergy |
Location | 4280 Sergeant Rd, Sioux City, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922008929 | NPI | - | NPPES |
0203331 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 23362 (Iowa) | Primary |
207KA0200X | Allergy & Immunology - Allergy | 23362 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr James Dean Oggel, MD 4280 Sergeant Rd, #230, Sioux City, IA 51106-4634 Ph: (712) 274-6884 | Mr James Dean Oggel, MD 4280 Sergeant Rd, #230, Sioux City, IA 51106-4634 Ph: (712) 274-6884 |
News Archive
Advances in diagnostic imaging have benefited children with otolaryngologic disease, allowing shorter hospital stays, fewer invasive procedures, more targeted surgical procedures, and earlier and more precise diagnoses. However, despite improved technology, concerns about exposure of children to ionizing radiation have recently come to the forefront, according to a commentary in the July 2012 issue of Otolaryngology-Head and Neck Surgery.
ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.
Solstice is excited to announce that it has received Health Utilization Management (HUM) Re-Accreditation from URAC, a Washington DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
New research funded by the British Heart Foundation (BHF) could pave the way for developing a test to predict pre-eclampsia in pregnant women and save the lives of mothers and babies across the world.
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases.
› Verified 4 days ago